S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer
Clinical trial NCT02164916 · COMPLETED
Trial details
- NCT number
- NCT02164916
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-11-13
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.